Puma Biotechnology reported $-1731000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acceleron Pharma XLRN:US $ -63.66M 0.06M
Agios Pharmaceuticals AGIO:US $ -89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Amgen AMGN:US $ 828M 1301M
Arena Pharmaceuticals ARNA:US $ -144.39M 12.4M
Array Technologies Inc ARRY:US 5.71M 7.35M
Biogen BIIB:US $ 485.7M 488.2M
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Cerulean Pharma CERU:US $ -9162930 1.84M
Clovis Oncology CLVS:US $ -57.58M 0.43M
Daiichi Sankyo 4568:JP Y 45769M 71437M
Esperion Therapeutics ESPR:US $ -32533000 50.29M
Exelixis EXEL:US $ 123.01M 127.62M
Gilead Sciences GILD:US $ 2246M 644M
Glaxosmithkline GSK:US $ 1675M 18M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
Macrogenics MGNX:US $ -40279000 11.01M
Mirati Therapeutics MRTX:US $ -164.19M 31.76M
Moderna Inc MRNA:US 3.06B 1.8B
Novartis NOVN:VX 3.48B 1.06B
Pfizer PFE:US $ 5914M 397M
Ptc Therapeutics PTCT:US $ -98.49M 0.34M
Puma Biotechnology PBYI:US $ -1.73M 21.69M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Seattle Genetics SGEN:US $ -89.6M 32.82M
Spectrum Pharmaceuticals SPPI:US $ -44.07M 10.38M
Tg Therapeutics TGTX:US $ -77.49M 11.71M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
Vanda Pharmaceuticals VNDA:US $ 12.37M 2.03M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
YTE INCY:US $ 140.84M 42.04M